Thursday, 8 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Mangalam Drugs and Organics Ltd

NSE: MANGALAM · BSE: 532637 · Pharmaceuticals & Biotechnology · 33 announcements

Share price
₹33.09
Market cap
₹52.38 Cr
Revenue (annual)
₹232.1 Cr
Net profit (annual)
₹-44.40 Cr
P/E (TTM)
-1.4×Sector 47.3×
Promoter holding
35.65%+0.00% QoQ
FII holding
0.11%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

18:39 IST BSE
Other Announcement

Mangalam Drugs and Organics Other Announcement

Mangalam Drugs and Organics Limited announced the appointment of new Statutory and Secretarial Auditors following the tenure completion of the previous Statutory Auditor.

17:11 IST BSE
Other Announcement

Mangalam Drugs and Organics Other Announcement

Mangalam Drugs and Organics Limited informed the exchanges that M/s. Ragini Chokshi & Co. has resigned as the company's Secretarial Auditor effective August 4, 2026.

16:30 IST NSE
Other Announcement

Mangalam Drugs and Organics Other Announcement

Mangalam Worldwide Limited filed a Title Search Report confirming clear and marketable title for its industrial land in Sanand, Ahmedabad. This routine legal disclosure verifies ownership.

16:17 IST BSE
Other Announcement

Mangalam Drugs and Organics Other Announcement

Mangalam Drugs and Organics filed its Annual Secretarial Compliance Report for FY2026. The report notes certain governance non-compliances regarding board and committee compositions.

18:03 IST BSE
Other Announcement

Mangalam Drugs and Organics Other Announcement

Mangalam Drugs & Organics Ltd submitted its quarterly compliance certificate under Regulation 74(5) of SEBI (DP) Regulations for the period ended March 31, 2026. The certificate, issued by MUFG Intime India, confirms the processing and cancellation of share certificates received for dematerialisation during the quarter.